Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Oracle
ORCL
|
+$881M |
| 2 |
DoorDash
DASH
|
+$403M |
| 3 |
Amgen
AMGN
|
+$403M |
| 4 |
Amazon
AMZN
|
+$282M |
| 5 |
Applied Materials
AMAT
|
+$231M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Abbott
ABT
|
+$592M |
| 2 |
Workday
WDAY
|
+$580M |
| 3 |
United Parcel Service
UPS
|
+$468M |
| 4 |
Apple
AAPL
|
+$438M |
| 5 |
Atlassian
TEAM
|
+$428M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.97% |
| 2 | Healthcare | 19.05% |
| 3 | Consumer Discretionary | 10.13% |
| 4 | Financials | 9.7% |
| 5 | Industrials | 9.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
Williams Companies
WMB
$85.8B
| $136M | 0.07% |
3,488,323
+59,425
| +2% | +$2.11M |
|
|
AXON
227
Axon Enterprise
AXON
$42.8B
| $136M | 0.07% |
433,627
-132,674
| -23% | -$36.9M |
|
228
EOG Resources
EOG
$77.7B
| $134M | 0.07% |
1,045,105
+78,619
| +8% | +$9.18M |
|
229
Palo Alto Networks
PANW
$256B
| $133M | 0.07% |
937,494
-2,013,202
| -68% | -$318M |
|
230
Welltower
WELL
$173B
| $132M | 0.07% |
1,409,444
-133,856
| -9% | -$12.1M |
|
231
Zurn Elkay Water Solutions
ZWS
$8.6B
| $129M | 0.07% |
3,865,128
-285,550
| -7% | -$8.79M |
|
232
Encompass Health
EHC
$11.3B
| $128M | 0.07% |
1,552,771
-40,588
| -3% | -$2.97M |
|
233
Saia
SAIA
$10.5B
| $128M | 0.07% |
218,337
-21,794
| -9% | -$11.4M |
|
234
Motorola Solutions
MSI
$72.1B
| $127M | 0.07% |
358,206
+335,496
| +1,477% | +$110M |
|
|
SUM
235
DELISTED
Summit Materials, Inc. Class A Common Stock
SUM
| $127M | 0.07% |
2,842,725
-436,627
| -13% | -$17.3M |
|
236
Revolution Medicines
RVMD
$38.5B
| $126M | 0.07% |
3,912,119
+1,712,639
| +78% | +$50.8M |
|
237
Gilead Sciences
GILD
$165B
| $126M | 0.07% |
1,713,743
-56,157
| -3% | -$4.32M |
|
238
EnerSys
ENS
$6.43B
| $123M | 0.07% |
1,306,505
+14,531
| +1% | +$1.37M |
|
|
SLNO
239
DELISTED
Soleno Therapeutics
SLNO
| $123M | 0.07% |
2,870,811
+346,914
| +14% | +$15.7M |
|
240
AstraZeneca
AZN
$269B
| $117M | 0.06% |
866,103
+1,475
| +0.2% | +$195K |
|
241
BellRing Brands
BRBR
$1.55B
| $116M | 0.06% |
1,957,680
-229,090
| -10% | -$13M |
|
242
Wynn Resorts
WYNN
$10.3B
| $115M | 0.06% |
1,125,718
+204,852
| +22% | +$20.3M |
|
243
Cullen/Frost Bankers
CFR
$10.5B
| $115M | 0.06% |
1,021,559
+161,580
| +19% | +$17.3M |
|
244
Gates Industrial Corporation Ltd.
GTES
$6.31B
| $114M | 0.06% |
6,464,750
-479,636
| -7% | -$6.94M |
|
245
Legend Biotech
LEGN
$3.65B
| $113M | 0.06% |
2,014,012
+148,855
| +8% | +$8.98M |
|
246
Autodesk
ADSK
$51.8B
| $112M | 0.06% |
430,415
-11,476
| -3% | -$2.9M |
|
247
Centene
CNC
$30.5B
| $111M | 0.06% |
1,416,967
-78,100
| -5% | -$6.03M |
|
248
Ares Management
ARES
$28.1B
| $111M | 0.06% |
834,615
+134,842
| +19% | +$17.2M |
|
249
Intercontinental Exchange
ICE
$87.2B
| $111M | 0.06% |
804,507
+687,817
| +589% | +$91.4M |
|
250
Williams-Sonoma
WSM
$27.5B
| $111M | 0.06% |
696,226
-145,858
| -17% | -$16.9M |
|
Similar funds
Janus Henderson Group's Q1 2024 Portfolio in Review
As of Q1 2024, Janus Henderson Group held 2,613 positions worth $183B, up 9.3% from $168B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Janus Henderson Group's Q1 2024 filing shows 67 new, 1,353 increased, 903 reduced and 85 closed positions. Its largest new stake was CG Oncology: 1,521,432 shares worth $66.8M. The largest sale was Abbott, an estimated $592M.
By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 33% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Janus Henderson Group's largest Q1 2024 buy was CG Oncology: 1,521,432 shares worth $66.8M.
- Janus Henderson Group added most to Oracle in Q1 2024, an estimated $881M increase.
- Janus Henderson Group's biggest Q1 2024 reduction was Abbott, cutting an estimated $592M.
- Janus Henderson Group fully exited Immunogen Inc in Q1 2024, selling an estimated $327M.
- Janus Henderson Group's ten largest holdings make up 28% of its $183B portfolio in Q1 2024.
- Janus Henderson Group opened 67 new positions and closed 85 in Q1 2024.
- Janus Henderson Group's portfolio value rose 9.3% quarter-over-quarter to $183B.
Based on Janus Henderson Group's 13F filing for Q1 2024, filed 15 May 2024.